Focused Ultrasound-Induced Blood–Brain Barrier Opening to Enhance Temozolomide Delivery for Glioblastoma Treatment: A Preclinical Study-Reference-Cited by-同舟云学术

Focused Ultrasound-Induced Blood–Brain Barrier Opening to Enhance Temozolomide Delivery for Glioblastoma Treatment: A Preclinical Study

Published:2013-03-19 Issue:3 Volume:8 Page:e58995
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Wei Kuo-Chen,Chu Po-Chun,Wang Hay-Yan Jack,Huang Chiung-Yin,Chen Pin-Yuan,Tsai Hong-Chieh,Lu Yu-Jen,Lee Pei-Yun,Tseng I-Chou,Feng Li-Ying,Hsu Peng-Wei,Yen Tzu-Chen,Liu Hao-Li

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference42 articles.

1. Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications;K Hynynen;Neuroimage,2005

2. The anatomy of astrocytomas;PC Burger;Mayo Clin Proc,1987

3. The fallacy of the localized supratentorial malignant glioma;EC Halperin;Int J Radiat Oncol Biol Phys,1988

4. Model selection in magnetic resonance imaging measurements of vascular permeability: Gadomer in a 9L model of rat cerebral tumor;JR Ewing;J Cereb Blood Flow Metab,2006

5. Permeability of different experimental brain tumor models to horseradish peroxidase;DR Groothuis;J Neuropathol Exp Neurol,1982

Cited by 186 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Focused ultrasound-mediated enhancement of blood–brain barrier permeability for brain tumor treatment: a systematic review of clinical trials;Journal of Neuro-Oncology;2024-08-29

2. Microbubble-Enhanced Focused Ultrasound for Infiltrating Gliomas;Biomedicines;2024-06-01

3. Consensus review on strategies to improve delivery across the blood-brain barrier including focused ultrasound;Neuro-Oncology;2024-05-21

4. Focused ultrasound as a treatment modality for gliomas;Frontiers in Neurology;2024-05-15

5. Repeated blood–brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I/II clinical trial;Nature Communications;2024-02-23